Guided Therapeutics (GTHP) Other Gross PP&E Adjustments (2019 - 2025)
Guided Therapeutics' Other Gross PP&E Adjustments history spans 9 years, with the latest figure at -$69000.0 for Q3 2025.
- For Q3 2025, Other Gross PP&E Adjustments rose 57.93% year-over-year to -$69000.0; the TTM value through Sep 2025 reached -$69000.0, up 57.93%, while the annual FY2024 figure was -$141000.0, 69.61% up from the prior year.
- Other Gross PP&E Adjustments for Q3 2025 was -$69000.0 at Guided Therapeutics, up from -$94000.0 in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at -$69000.0 in Q3 2025 and bottomed at -$481000.0 in Q4 2022.
- The 5-year median for Other Gross PP&E Adjustments is -$285000.0 (2023), against an average of -$280210.5.
- The largest annual shift saw Other Gross PP&E Adjustments tumbled 536.07% in 2021 before it soared 69.61% in 2024.
- A 5-year view of Other Gross PP&E Adjustments shows it stood at -$372000.0 in 2021, then fell by 29.3% to -$481000.0 in 2022, then rose by 3.53% to -$464000.0 in 2023, then skyrocketed by 69.61% to -$141000.0 in 2024, then surged by 51.06% to -$69000.0 in 2025.
- Per Business Quant, the three most recent readings for GTHP's Other Gross PP&E Adjustments are -$69000.0 (Q3 2025), -$94000.0 (Q2 2025), and -$118000.0 (Q1 2025).